Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 5 | 2024 | 5443 | 1.120 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 2023 | 49 | 0.860 |
Why?
|
| Polyamines | 1 | 2023 | 133 | 0.810 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2021 | 76 | 0.730 |
Why?
|
| Glutamine | 1 | 2024 | 578 | 0.720 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 1755 | 0.690 |
Why?
|
| Caloric Restriction | 2 | 2013 | 300 | 0.630 |
Why?
|
| Mucoproteins | 1 | 2017 | 49 | 0.580 |
Why?
|
| Integrin beta4 | 1 | 2017 | 29 | 0.560 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2018 | 558 | 0.520 |
Why?
|
| Genes, ras | 1 | 2018 | 665 | 0.490 |
Why?
|
| Laminin | 1 | 2017 | 406 | 0.490 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2018 | 1766 | 0.420 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3610 | 0.380 |
Why?
|
| Ornithine | 2 | 2023 | 79 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 2460 | 0.350 |
Why?
|
| Extracellular Matrix | 2 | 2017 | 1739 | 0.350 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 1943 | 0.350 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2013 | 1119 | 0.340 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2017 | 2884 | 0.290 |
Why?
|
| Lipid Metabolism | 2 | 2006 | 1901 | 0.270 |
Why?
|
| Arginine | 2 | 2023 | 923 | 0.270 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3695 | 0.240 |
Why?
|
| Pancreatic Hormones | 1 | 2024 | 12 | 0.230 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 861 | 0.230 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 276 | 0.230 |
Why?
|
| Insulin | 2 | 2018 | 6607 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2018 | 5422 | 0.220 |
Why?
|
| Proteins | 2 | 2017 | 6006 | 0.210 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 13576 | 0.200 |
Why?
|
| Oncogene Proteins | 2 | 2017 | 718 | 0.190 |
Why?
|
| Enzyme Stability | 1 | 2021 | 219 | 0.180 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3939 | 0.170 |
Why?
|
| Cholesterol | 2 | 2006 | 2912 | 0.170 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3334 | 0.160 |
Why?
|
| Neoplasms | 2 | 2023 | 22385 | 0.160 |
Why?
|
| Autophagy | 2 | 2018 | 1351 | 0.150 |
Why?
|
| Immune System | 1 | 2023 | 801 | 0.150 |
Why?
|
| Codon, Terminator | 1 | 2018 | 125 | 0.150 |
Why?
|
| Pancreas | 1 | 2024 | 1702 | 0.140 |
Why?
|
| Obesity | 2 | 2017 | 13084 | 0.130 |
Why?
|
| Starvation | 1 | 2017 | 141 | 0.130 |
Why?
|
| Transcription Factors | 3 | 2006 | 12166 | 0.130 |
Why?
|
| Mice | 10 | 2023 | 82017 | 0.130 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2006 | 63 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 1769 | 0.110 |
Why?
|
| Animals | 12 | 2023 | 169337 | 0.110 |
Why?
|
| Pyrophosphatases | 1 | 2013 | 142 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 17135 | 0.100 |
Why?
|
| Amino Acids | 1 | 2018 | 1716 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 9614 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1623 | 0.090 |
Why?
|
| Glucose | 2 | 2014 | 4352 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2017 | 14481 | 0.080 |
Why?
|
| Serine | 1 | 2011 | 831 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2023 | 4738 | 0.070 |
Why?
|
| Humans | 12 | 2024 | 768393 | 0.070 |
Why?
|
| Cell Survival | 1 | 2017 | 5792 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 113 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2017 | 4177 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 8634 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 6132 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2018 | 23631 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1839 | 0.060 |
Why?
|
| Mitochondria | 1 | 2017 | 3675 | 0.060 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2003 | 15 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2009 | 2632 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3587 | 0.050 |
Why?
|
| Cell Line | 1 | 2017 | 15597 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2003 | 230 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2394 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 773 | 0.040 |
Why?
|
| Homeostasis | 2 | 2014 | 3349 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 2225 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2006 | 2856 | 0.030 |
Why?
|
| Gene Expression | 1 | 2009 | 7598 | 0.030 |
Why?
|
| Cell Communication | 1 | 2003 | 1660 | 0.030 |
Why?
|
| Genomics | 1 | 2011 | 5916 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 16721 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2003 | 3663 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18362 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9516 | 0.030 |
Why?
|
| Cachexia | 1 | 2014 | 202 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.020 |
Why?
|
| Ketoglutaric Acids | 1 | 2011 | 76 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 3981 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 234 | 0.020 |
Why?
|
| Liver | 1 | 2005 | 7574 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2017 | 0.020 |
Why?
|
| Fetal Viability | 1 | 2006 | 23 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2014 | 894 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11668 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1193 | 0.020 |
Why?
|
| Male | 2 | 2017 | 364902 | 0.020 |
Why?
|
| Female | 3 | 2017 | 397089 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 414 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 21162 | 0.010 |
Why?
|
| Polyhydroxyethyl Methacrylate | 1 | 2003 | 30 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2952 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2006 | 841 | 0.010 |
Why?
|
| Caseins | 1 | 2003 | 105 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 250 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2836 | 0.010 |
Why?
|
| Connexin 43 | 1 | 2003 | 202 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2003 | 354 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2006 | 1176 | 0.010 |
Why?
|
| Connexins | 1 | 2003 | 355 | 0.010 |
Why?
|
| Fetal Development | 1 | 2006 | 771 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1110 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 1468 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2006 | 2066 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 2812 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10478 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 8326 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9343 | 0.010 |
Why?
|
| Melanoma | 1 | 2011 | 5705 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11120 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19022 | 0.000 |
Why?
|
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_